If An Alzheimer’s Drug Succeeds Could Our Health System Handle it?

Philanthropists such as Bill Gates are investing millions in Alzheimer’s research. But a new study proposes that the U.S. healthcare system wouldn’t have the bandwidth required to treat the influx of patients expected over the next two decades.